“Savara Pharmaceuticals: Emerging Specialty Pharmaceutical Company Focused on Rare Respiratory Diseases”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

TaneliJouhikainenPresImage
Taneli Jouhikainen of Savara joined us for World Orphan Drug Congress USA 2015 to present about ‘Emerging Specialty in Pharmaceutical Company Focused on Rare Respiratory Diseases” 
Download the presentation now to learn about:

  • Lead product: AeroVanc
  • Summary of AeroVanc Development
  • Next steps for AeroVanc and Savara

…and much more!

Get your copy here!

To find out more about  Savara and AeroVanc , attend World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment